Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Presenilin 2 deficiency facilitates Aβ-induced neuroinflammation and injury by upregulating P2X7 expression
Juliang Qin, Xiaoyu Zhang, Ziqiang Wang, et al.
Science China Life Sciences (2017) Vol. 60, Iss. 2, pp. 189-201
Closed Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

The genes associated with early-onset Alzheimer’s disease
Meng-Hui Dai, Hui Zheng, Ling-dan Zeng, et al.
Oncotarget (2017) Vol. 9, Iss. 19, pp. 15132-15143
Open Access | Times Cited: 110
P2X7 Receptors Amplify CNS Damage in Neurodegenerative Diseases
Péter Illés
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 17, pp. 5996-5996
Open Access | Times Cited: 102
The Role of P2X7 Receptor in Alzheimer’s Disease
Linda Francistiová, Carolina Bianchi, Caterina Di Lauro, et al.
Frontiers in Molecular Neuroscience (2020) Vol. 13
Open Access | Times Cited: 54
P2X7 receptor in inflammation and pain
Shiqi Hu, Jialing Hu, Fei-long Zou, et al.
Brain Research Bulletin (2022) Vol. 187, pp. 199-209
Closed Access | Times Cited: 33
Actin-mediated Microglial Chemotaxis via G-Protein Coupled Purinergic Receptor in Alzheimer’s Disease
Rashmi Ranjan Das, Subashchandrabose Chinnathambi
Neuroscience (2020) Vol. 448, pp. 325-336
Closed Access | Times Cited: 40
Glial Purinergic Signaling in Neurodegeneration
Marie J. Pietrowski, Amr Ahmed Gabr, Stanislav Kozlov, et al.
Frontiers in Neurology (2021) Vol. 12
Open Access | Times Cited: 36
Chronic seizures induce sex-specific cognitive deficits with loss of presenilin 2 function
Kevin M. Knox, Megan Beckman, Carole Smith, et al.
Experimental Neurology (2023) Vol. 361, pp. 114321-114321
Closed Access | Times Cited: 13
The P2X7 receptor: a new therapeutic target in Alzheimer’s disease
Péter Illés, Patrizia Rubini, Lumei Huang, et al.
Expert Opinion on Therapeutic Targets (2019) Vol. 23, Iss. 3, pp. 165-176
Closed Access | Times Cited: 42
miR-212-3p attenuates neuroinflammation of rats with Alzheimer's disease via regulating the SP1/BACE1/NLRP3/Caspase-1 signaling pathway
Wei Nong, Chuanhong Bao, Yixin Chen, et al.
Bosnian Journal of Basic Medical Sciences (2022)
Open Access | Times Cited: 20
Clinical Significance of Early-Onset Alzheimer’s Mutations in Asian and Western Populations: A Scoping Review
Prevathe Poniah, Aswir Abd Rashed, Julaina Abdul Jalil, et al.
Genes (2025) Vol. 16, Iss. 3, pp. 345-345
Open Access
Anti-diabetic vanadyl complexes reduced Alzheimer’s disease pathology independent of amyloid plaque deposition
Yaqiong Dong, Tessandra Stewart, Yue Zhang, et al.
Science China Life Sciences (2018) Vol. 62, Iss. 1, pp. 126-139
Closed Access | Times Cited: 37
Pathological Changes in Alzheimer’s Disease Analyzed Using Induced Pluripotent Stem Cell-Derived Human Microglia-Like Cells
Mei Xu, Lin Zhang, Gang Liu, et al.
Journal of Alzheimer s Disease (2018) Vol. 67, Iss. 1, pp. 357-368
Closed Access | Times Cited: 37
Early-Onset Familial Alzheimer Disease Variant PSEN2 N141I Heterozygosity is Associated with Altered Microglia Phenotype
Susan Fung, C. Smith, Katherine E. Prater, et al.
Journal of Alzheimer s Disease (2020) Vol. 77, Iss. 2, pp. 675-688
Open Access | Times Cited: 28
P2X7R influences tau aggregate burden in human tauopathies and shows distinct signalling in microglia and astrocytes
Paula Beltran-Lobo, Martina M. Hughes, Claire Troakes, et al.
Brain Behavior and Immunity (2023) Vol. 114, pp. 414-429
Open Access | Times Cited: 10
Identification of a Novel Wnt Antagonist Based Therapeutic and Diagnostic Target for Alzheimer’s Disease Using a Stem Cell-Derived Model
Manasi Patil, Naisarg Gamit, Arun Dharmarajan, et al.
Bioengineering (2023) Vol. 10, Iss. 2, pp. 192-192
Open Access | Times Cited: 7
Comprehensive insights into potential roles of purinergic P2 receptors on diseases: Signaling pathways involved and potential therapeutics
Yanshuo Guo, Tianqi Mao, Yafei Fang, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 2
Identification of Leukocyte Surface P2X7 as a Biomarker Associated with Alzheimer’s Disease
Yihan Li, Xin Huang, Christopher Fowler, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 14, pp. 7867-7867
Open Access | Times Cited: 12
γ-Secretase in microglia - implications for neurodegeneration and neuroinflammation
Jochen Walter, Nadja Kemmerling, Patrick Wunderlich, et al.
Journal of Neurochemistry (2017) Vol. 143, Iss. 4, pp. 445-454
Open Access | Times Cited: 18
P2X7 Receptor: an Emerging Target in Alzheimer’s Disease
Qiang Huang, Jun Ying, Wen Yu, et al.
Molecular Neurobiology (2023) Vol. 61, Iss. 5, pp. 2866-2880
Open Access | Times Cited: 5
Hippocampal purinergic P2X7 receptor level is increased in Alzheimer’s disease patients, and associated with amyloid and tau pathologies
Cinzia Maschio, Junlong Wang, Upasana Maheshwari, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
The abuse of anesthetic propofol: associated with cognitive impairment
Weili Zhu, Wen Zhang, Jiali Li, et al.
Science China Life Sciences (2018) Vol. 61, Iss. 11, pp. 1428-1431
Closed Access | Times Cited: 5
Increased regional P2X7R uptake detected by [18F]GSK1482160 PET in a tauopathy mouse model
Yanyan Kong, Lei Cao, Jiao Wang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Ten years of achievements in biological and medical sciences
Mingyao Liu, Tieliu Shi
Science China Life Sciences (2017) Vol. 60, Iss. 2, pp. 111-115
Open Access | Times Cited: 3
Novel Therapeutic Targets for Treating Alzheimer’s Disease
Magham Sai Varshini, Ammu V. V. V. Ravi Kiran, Kusuma Kumari Garikapati, et al.
(2023), pp. 19-39
Closed Access | Times Cited: 1
Role of caspases, apoptosis and additional factors in pathology of Alzheimer's disease
Anil Gupta
Elsevier eBooks (2021), pp. 69-151
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top